Groups Sue CMS Over $1.6B Cut To 340B Payment

coapharm2017-12-04T14:20:13+00:00December 4, 2017|

Making Medicines Affordable: A National Imperative — A Review

coapharm2017-12-04T14:16:04+00:00December 4, 2017|

The FDA Ushers In a New Era in Cancer Treatment

coapharm2017-12-04T14:13:19+00:00December 4, 2017|

Op-Ed: 340B Coalition Working to Restore Transparency to Low-Income Rx Drug Program

coapharm2017-12-01T14:42:36+00:00December 1, 2017|

Report: Here’s What The Feds Can Do To Cut Drug Prices

coapharm2017-12-01T14:41:12+00:00December 1, 2017|

Fake Drugs Are A Major Global Problem, WHO Reports

coapharm2017-11-30T20:39:59+00:00November 30, 2017|

North Dakota Judge Denies Preliminary Injunction to PBMs

coapharm2017-11-29T14:29:59+00:00November 29, 2017|

Market Distortions Caused by the 340B Prescription Drug Program

coapharm2017-11-29T14:27:20+00:00November 29, 2017|

A Failure to Heal

coapharm2017-11-29T14:26:08+00:00November 29, 2017|

The Sopranos of the pharmaceutical industry

coapharm2017-11-29T14:24:28+00:00November 29, 2017|